The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Sulforaphane treatment in men with recurrent prostate cancer.
Joshi J. Alumkal
No relevant relationships to disclose
Rachel Slottke
No relevant relationships to disclose
Motomi Mori
No relevant relationships to disclose
Jacob Schwartzman
No relevant relationships to disclose
Julie Nicole Graff
No relevant relationships to disclose
Tomasz M. Beer
Research Funding - Kuni Foundation
Christopher W. Ryan
No relevant relationships to disclose
Dennis R Koop
No relevant relationships to disclose
Ganesh Cherala
No relevant relationships to disclose
Myrna Munar
No relevant relationships to disclose
Jason Frederick Flamiatos
No relevant relationships to disclose
Lina Gao
No relevant relationships to disclose
Erin Tucker
No relevant relationships to disclose